If it's Planned, Will They Build it? How Many Pharma-Biotech Capital Projects Actually Make Construction?

SUGAR LAND--January 19, 2015--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--When considering the Pharmaceutical-Biotech Industry's reported capital project spending for any given year, it is important to analyze the projects after they are first reported. Utilizing analysis tools, such as Gap Measurement and Project Fallout, help to illuminate an accurate view of project-spending patterns. From 2012-14, 71% of reported pharma-biotech projects in a given year made it to construction.

Within this article: Outlook for cash-intensive projects in the Pharmaceutical-Biotech Industry.